| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
|
Jiang, Haiping
|
|
2015
|
76 |
1 |
p. 197-203
|
article
|
| 2 |
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
|
Machiels, J.-P.
|
|
|
76 |
1 |
p. 13-20
|
article
|
| 3 |
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
|
Machiels, J.-P.
|
|
2015
|
76 |
1 |
p. 13-20
|
article
|
| 4 |
A single-dose PK study of onapristone including the effect of food on absorption
|
Rezai, Keyvan
|
|
2015
|
76 |
1 |
p. 171-177
|
article
|
| 5 |
Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients
|
McCune, Jeannine S.
|
|
2015
|
76 |
1 |
p. 85-96
|
article
|
| 6 |
Comparison of saliva interleukin-2 concentration to the condition of gums in children with acute lymphoblastic leukaemia during anti-tumour treatment
|
Pels, Elżbieta
|
|
2015
|
76 |
1 |
p. 205-210
|
article
|
| 7 |
Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer
|
Katsuya, Yuki
|
|
2015
|
76 |
1 |
p. 125-132
|
article
|
| 8 |
Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy
|
Wang, Lin-run
|
|
2015
|
76 |
1 |
p. 163-170
|
article
|
| 9 |
Development of a new equation to estimate creatinine clearance in cancer patients
|
Chu, Michael P.
|
|
2015
|
76 |
1 |
p. 117-124
|
article
|
| 10 |
Direct and indirect targeting of MYC to treat acute myeloid leukemia
|
Brondfield, Sam
|
|
2015
|
76 |
1 |
p. 35-46
|
article
|
| 11 |
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
|
Matsuda, Chu
|
|
2015
|
76 |
1 |
p. 97-103
|
article
|
| 12 |
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma
|
Burke, John M.
|
|
|
76 |
1 |
p. 211-216
|
article
|
| 13 |
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma
|
Burke, John M.
|
|
2015
|
76 |
1 |
p. 211-216
|
article
|
| 14 |
Endometrial cancer: redefining the molecular-targeted approach
|
Silva, Jesse Lopes da
|
|
2015
|
76 |
1 |
p. 1-11
|
article
|
| 15 |
Erratum to: Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
|
Ozdemir, Nuriye
|
|
2015
|
76 |
1 |
p. 217
|
article
|
| 16 |
Extension of the Calvert formula to patients with severe renal insufficiency
|
Oguri, Tomoyo
|
|
2015
|
76 |
1 |
p. 53-59
|
article
|
| 17 |
Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
|
Kim, Yi Rang
|
|
2015
|
76 |
1 |
p. 141-153
|
article
|
| 18 |
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients
|
Staveren, Maurice C. van
|
|
2015
|
76 |
1 |
p. 47-52
|
article
|
| 19 |
Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol)
|
Hill, C. U. F. Kelly
|
|
2015
|
76 |
1 |
p. 179-185
|
article
|
| 20 |
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
|
Kotaka, Masahito
|
|
2015
|
76 |
1 |
p. 75-84
|
article
|
| 21 |
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
|
Cihalova, Daniela
|
|
2015
|
76 |
1 |
p. 105-116
|
article
|
| 22 |
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with 18F-3′deoxy-3′fluoro-l-thymidine positron emission tomography/computed tomography
|
Bruce, Justine Yang
|
|
2015
|
76 |
1 |
p. 187-195
|
article
|
| 23 |
Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
|
Inoue, Yusuke
|
|
2015
|
76 |
1 |
p. 155-161
|
article
|
| 24 |
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
|
Wainberg, Zev A.
|
|
2015
|
76 |
1 |
p. 61-67
|
article
|
| 25 |
Pilot study of modified FOLFOX6 adjuvant chemotherapy for high-risk rectal cancer treated with neoadjuvant chemoradiotherapy
|
Lee, Soo Jung
|
|
2015
|
76 |
1 |
p. 29-34
|
article
|
| 26 |
Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
|
Nakayama, Izuma
|
|
2015
|
76 |
1 |
p. 133-139
|
article
|
| 27 |
Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial
|
Xiao, Jian
|
|
2015
|
76 |
1 |
p. 21-27
|
article
|
| 28 |
Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia
|
Watanabe, Naohiro
|
|
2015
|
76 |
1 |
p. 69-74
|
article
|
Journal description